Abstract: A prosthetic arm apparatus including a plurality of segments that provide a user of the prosthetic arm apparatus with substantially the same movement capability and function as a human arm. The segments are connectable to one another and connectable to a prosthetic support apparatus that may be adorned by the user. Some segments may provide movement about more than one axis using a single actuator. The prosthetic arm apparatus may include a user interface incorporated therein and may include one or more communication systems for communicating with external devices.

Abstract: Described herein are devices for applying conductive gels to electrodes and the gel-laminated electrodes produced thereby. The devices permit the reuse of the electrodes by easily applying fresh gels to them for each subsequent use. In a first example embodiment, all of the components of the laminating device are provided in a single housing. In a second example embodiment, the gel applying and drive components are housed within the device, and a replaceable cartridge houses the gels and the gel delivery components. Also described herein are dispensers for storing and dispensing conductive gels that can be readily applied to and removed from an electrode.

Abstract: Described herein are devices for applying conductive gels to electrodes and the gel-laminated electrodes produced thereby. The devices permit the reuse of the electrodes by easily applying fresh gels to them for each subsequent use. In a first example embodiment, all of the components of the laminating device are provided in a single housing. In a second example embodiment, the gel applying and drive components are housed within the device, and a replaceable cartridge houses the gels and the gel delivery components. Also described herein are dispensers for storing and dispensing conductive gels that can be readily applied to and removed from an electrode.

Abstract: The invention features new helper virus-free methods for making herpesvirus amplicon particles that can be used in immunotherapies, including those for treating any number of infectious diseases and cancers (including chronic lymphocytic leukemia, other cancers in which blood cells become malignant, lymphomas (e.g. Hodgkin's lymphoma or non-Hodgkin's type lymphomas). Described herein are methods of making helper virus-free HSV amplicon particles; cells that contain those particles (e.g., packaging cell lines or patients'cells, infected in vivo or ex vivo); particles produced according to those methods; and methods of treating a patient with an hf-HSV particle made according to those methods.